A Pre-operative Window Study of Letrozole Plus PR Agonist (Megestrol Acetate) Versus Letrozole Alone in Post-menopausal Patients With ER-positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Megestrol Acetate 40 MG|DRUG: Megestrol Acetate 160 MG|DRUG: Letrozole
Sponsor: Cambridge University Hospitals NHS Foundation Trust
Collaborators: Anticancer Fund, Belgium